TP53 and hepatocellular carcinoma: According to these results, the strongest anti-proliferative effect of gossypol was achieved 48 h after treatment with 50 μM, with human-derived hepatoma cells being the most susceptible cell lines, which showed a p53-independent rapid reduction in viability.